Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis.
Artificial intelligence
High resolution computed tomography
Interstitial lung disease
Prognosis
Systemic sclerosis
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
19 Apr 2023
19 Apr 2023
Historique:
received:
01
12
2022
revised:
10
03
2023
accepted:
27
03
2023
medline:
19
4
2023
pubmed:
19
4
2023
entrez:
19
04
2023
Statut:
aheadofprint
Résumé
Stratifying the risk of death in systemic sclerosis (SSc)-related interstitial lung disease (SSc-ILD) is a challenging issue. The extent of lung fibrosis on high-resolution computed tomography (HRCT) is often assessed by a visual semi-quantitative method that lacks reliability. We aimed to assess the potential prognostic value of a deep-learning based algorithm allowing for automated quantification of ILD on HRCT in patients with SSc. We correlated the extent of ILD with the occurrence of death during follow-up and evaluated the additional value of ILD extent to predict death based on a prognostic model including well-known risk factors in SSc. We included 318 patients with SSc among which 196 had ILD; median follow-up was 94 months (interquartile range 73-111). Mortality rate was 1.6% at 2 years and 26.3% at 10 years. For each 1% increase in the baseline ILD extent (up to 30% of the lung), the risk of death at 10 years was increased 4% (hazard ratio 1.04, 95%CI 1.01-1.07, p = 0.004). We constructed a risk prediction model that showed good discrimination for 10-year mortality (c index 0.789). Adding the automated quantification of ILD significantly improved the model for 10-year survival (p = 0.007) but its discrimination only marginally. However, it improved the ability to predict 2-year mortality (difference in time-dependent AUC 0.043, 95%CI 0.002-0.084, p = 0.040). The deep-learning-based, computer-aided quantification of ILD extent on HRCT provides an effective tool for risk stratification in SSc. It might help identify patients at short-term risk of death.
Identifiants
pubmed: 37074923
pii: 7131095
doi: 10.1093/rheumatology/kead164
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.